TrialThe Journal of clinical endocrinology and metabolism2011

Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.

Hala Tfayli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.